The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations
Abstract
In contrast to other common types of malignant tumors, the vast majority of gastroenteropancreatic [endocrine pancreatic (EPTs) and carcinoid] neuroendocrine tumors (NETs) are well differentiated and slowly growing with only a minority showing an aggressive behavior. NETs can produce a variety of metabolically active substances (hormones and amines) leading to distinct clinical syndromes (functioning tumors). However, the majority are non-functioning and present either with locally advanced disease giving rise to site-specific symptoms or distant metastases mainly to the liver. Patients with midgut carcinoid tumors and liver metastases may experience symptoms of the carcinoid syndrome (flushing and diarrhoea), and develop carcinoid heart disease. In such patients, mesenteric involvement may lead to ischaemia and/or intestinal obstruction due to a surrounding desmoplastic reaction with kinking of the bowel and vascular encasement. Approximately 30–40% of these patients may require emergency surgery and are diagnosed at a relatively early stage before liver metastases have occurred.These distinct features in tumor growth, secretory capacity and localisation are consequently reflected in the wide variation in clinical presentation of different NETs. Moreover, a number of NETs may be found incidentally when patients undergo surgery for unrelated reasons or may be an unexpected finding in the histopathological specimen as with appendiceal carcinoids. Accordingly, the need for diagnostic procedures and the choice of imaging methods varies considerably depending on the patient’s tumor status at presentation.The various aspects to consider in the choice of imaging methods are related to primary tumor detection, evaluation of its local extent and relation to adjacent anatomical structures, staging of the tumor concerning regional and distant metastases, evaluation of tumor somatostatin receptor density, therapy monitoring and detection of recurrent disease. In this review, the various applications of current radiological modalities are described, including computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US), contrast-enhanced US (CEUS), endoscopic US (EUS) and intraoperative US (IOUS). The corresponding applications of nuclear medicine procedures are presented separately.The participants of the consensus meeting considered the use of various radiological methods for the different imaging applications in relation to documented available figures on sensitivity and specificity together with the expertise of the participants; availability of the various modalities was also taken into account. Further aspects considered were patient preparation and information, clinical information communicated to the radiologist for optimisation of the examination procedure and imaging interpretation, imaging protocols, reporting of results and radiation dose administered to the patient. The use of intravenous (i.v.) contrast media (CM) for CT in patients with impaired renal function and in subjects with previous experience of side effects by i.v. CM was also addressed.In general, data from the literature regarding the sensitivity and specificity of the various radiological modalities used for the diagnosis of NETs suffer from the small number of patients included and the absence of a reliable gold standard for verification of the imaging results. Quite frequently, detection rate is reported instead of sensitivity and specificity. Results are sometimes based on a patient-by-patient analysis and in other reports the results are also, or instead, lesion-by-lesion based. The detection rate merely states the proportion of patients with disease that is detected by the imaging method out of all examined subjects. The sensitivity is instead calculated with reference to a gold standard and equals the proportion of patients with the disease detected by the imaging method out of all patients with the disease according to the gold standard [sensitivity = true positive observations/(true positive observations + false negative observations)]. This review includes imaging data on sensitivity and specificity on a patient-by-patient basis. Detection rates are instead based on lesion-by-lesion analyses and report the proportion positive imaging results in patients with biochemically/clinically evident NETs. Also, the studies that were considered used current standards of imaging. Thus, studies in which incremental CT was performed, those without adequate contrast enhancement, and studies that utilised low field strength MRI (<0.5 T) were excluded.The current presentation, on radiological imaging of NETs, was adapted to the layout of the template for the whole consensus document and is divided into paragraphs according to the various radiological imaging techniques.Modern spiral or helical CT, generally multidetector CT (MDCT) scanners are available in most radiology departments and CT has currently replaced several imaging a
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
Rösch, T., Lightdale, C. J., Botet, J. F., Boyce, G. A., Sivak, M. V., Yasuda, K., Heyder, N., Palazzo, L., Dancygier, H., Schusdziarra, V., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262601 · Cited by 713
Anderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Dromain, C., de Baere, T., Lumbroso, J., Caillet, H., Laplanche, A., Boige, V., Ducreux, M., Duvillard, P., Elias, D., Schlumberger, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.013 · Cited by 389
Gouya, H., Vignaux, O., Augui, J., Dousset, B., Palazzo, L., Louvel, A., Chaussade, S., & Legmann, P. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.4.1810987 · Cited by 312
Islet Cell Tumor of the Pancreas: Biphasic CT versus MR Imaging in Tumor Detection
Ichikawa, T., Peterson, M. S., Federle, M. P., Baron, R. L., Haradome, H., Kawamori, Y., Nawano, S., & Araki, T. (2000) · Radiology · doi:10.1148/radiology.216.1.r00jl26163 · Cited by 275
Thoeni, R. F., Mueller-Lisse, U. G., Chan, R., Do, N. K., & Shyn, P. B. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe32483 · Cited by 256
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study
Koopmans, K. P., de Vries, E. G., Kema, I. P., Elsinga, P. H., Neels, O. C., Sluiter, W. J., van der Horst-Schrivers, A. N., & Jager, P. L. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70801-4 · Cited by 237
Zimmer, T., Stölzel, U., Bäder, M., Koppenhagen, K., Hamm, B., Buhr, H., Riecken, E. O., & Wiedenmann, B. (1996) · Gut · doi:10.1136/gut.39.4.562 · Cited by 223
Cited by
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Zaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
Caplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., Perren, A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 714
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationNANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Metadata
- Authors
- Sundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-12-13
- Volume
- 90
- Issue
- 2
- Pages
- 167-183
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W1984619754
- Cited by
- 287
- References
- 30
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations. https://app.cochat.ai/papers/10.1159/000184855
- The paper
- Sundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U. (2009). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations. Neuroendocrinology. https://doi.org/10.1159/000184855
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.